Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma Catches a Break: Alzheimer's Drug Development Gets Rare Congressional Boost

Jun 01 2007

• By Kate Rawson

Related Content

Antibiotic Assistance

Jun 01 2007

Getting the Bugs Out of Antibiotic R&D: Commercial Implications of a Higher Regulatory Hurdle

Jun 01 2007

FDA's Temple of Wisdom: The Dean of Drug Development

May 01 2007

The Politics of Drug Safety: An FDA Whistleblower's Push for Reform

Mar 01 2007

Rethinking Alzheimer's: Mapping Out an Approval Process

Feb 01 2006

Imaging Standards for Clinical Trials: A Picture Worth 1,000 Guidance Documents

Apr 01 2007

Related Companies

GSK plc

Sanofi

Merck & Co., Inc.

Wyeth

Gyre Therapeutics, Inc.

Elan Corporation

AstraZeneca PLC

Additional Topics

Business Strategies Clinical Trials Regulation BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.